Dr. Kristen Fortney adds depth to this definition, stating, "A longevity biotechnology company is focused on developing interventions that target the biological drivers of aging to prevent ...

Dr. Kristen Fortney is the co-founder and CEO of BioAge. Kristen Fortney is the co-founder and CEO of BioAge, a clinical-stage biotechnology company developing a pipeline of treatments to extend ...

The answer really is just diet and exercise − there are no therapies yet,” said Kristen Fortney, CEO of BioAge ... Drug Administration Commissioner Dr. Robert Califf at the Targeting Healthy ...

The company discontinued its azelaprag trial in December after phase 2 data raised liver-related safety concerns, a move that CEO and co-founder Kristen Fortney called a “significant ...

As a postdoctoral researcher at Stanford University, Kristen Fortney used bioinformatics to study the genetics of supercentenarians — people who live to the age of 110 and beyond. Now she is at ...

Kristen Fortney, cofounder and CEO of BioAge Labs. From the San Francisco Business Times. BioAge Labs Inc., which has turned its aging diseases focus toward the hot area of obesity drugs ...

"We are delighted to welcome Michael to BioAge's board of directors," said Kristen Fortney, PhD, CEO and co-founder of BioAge Labs. "His expertise as a physician and researcher in the field of ...